![Fig. 2. Dose–response effects of intraplantar nor-BNI on the antinociceptive action (% maximum possible effect [MPE]) of (A ) FE 200665 (100 μg), (B ) FE 200666 (30 μg), and (C ) U-69,593 (100 μg). P < 0.05, analysis of variance (linear regression).](https://asa2.silverchair-cdn.com/asa2/content_public/journal/anesthesiology/94/6/10.1097_00000542-200106000-00018/2/18ff2.png?Expires=1716278269&Signature=dtZtq6HThrNLgjLE8e3BUFad9RXFTOzR6HQhQJcddPqGyMAh2xlSaO2IF3TifGtAqGTGwLwunNPIU2n3y7di5nDeuJ8w35lLOfnI2qiloDOwZ7I0B1TVKuUwQ30mdr17UP4PW5bc0Wo~isJ-M3TliEQ0X-CV2CDat-P4niMOWa5ceTYYSElzMV0qBi48V65KBAepBx46Dqk~Rpfpd7R3GFECzYB0169vZTKJMpBM4BDSFqf~W65PWlQn1MGS1GDC4xrJ-Nm4R9yTsv~WTo~3KwEPWAf8y0rSq9ib2gcH~Ls84e-3qO~8AWF4tv0-AloFzQLCYX~MAaSqfKWN2bmkvw__&Key-Pair-Id=APKAIE5G5CRDK6RD3PGA)
Fig. 2. Dose–response effects of intraplantar nor-BNI on the antinociceptive action (% maximum possible effect [MPE]) of (A ) FE 200665 (100 μg), (B ) FE 200666 (30 μg), and (C ) U-69,593 (100 μg). P < 0.05, analysis of variance (linear regression).
Fig. 2. Dose–response effects of intraplantar nor-BNI on the antinociceptive action (% maximum possible effect [MPE]) of (A ) FE 200665 (100 μg), (B ) FE 200666 (30 μg), and (C ) U-69,593 (100 μg). P < 0.05, analysis of variance (linear regression).
